
Sharp decrease in MLYS’s short interest leads to decline in days-to-cover ratio
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Mineralys Therapeutics Inc’s recent filing unveils that its Chief Medical Officer Rodman David Malcom unloaded Company’s shares for reported $0.17
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Mineralys Therapeutics Inc’s filing revealed that its Chief Medical Officer Rodman David Malcom unloaded Company’s shares for reported $0.17 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Mineralys Therapeutics Inc’s recent filing unveils that its Chief Medical Officer Rodman David Malcom unloaded Company’s shares for reported $0.17
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Mineralys Therapeutics
Mineralys Therapeutics Inc’s filing revealed that its Director Slingsby Brian Taylor acquired Company’s shares for reported $3.5 million on Mar